Baxter and Miromatrix Join Forces to Develop Bioengineered Liver

Baxter and Miromatrix Medical are teaming up to develop a unique therapy for patients with acute liver failure (ALF), the companies announced Wednesday.

The partners will combine Miromatrix’s single-use bioengineered liver with Baxter’s PrisMax system, which is designed to provide individualized therapies to patients.